Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NecstGen
Leiden, South Holland, Netherlandsnecstgen.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
NecstGen enables academic and industry partners to translate early-stage research into clinical-grade cell and gene therapies by providing GMP-compliant development, manufacturing services, cleanroom rental, and consultancy. It has recently partnered with Galapagos to manufacture decentralized CAR-T products for hematological cancers.
- Therapeutic areas
- OncologyEndocrinologyRare Diseases
- Modalities
- Cell therapyGene therapyViral vector-based therapiesStem cell therapyRegenerative medicine therapies
- Industry
- Contract Manufacturing Organization
02
Partnerships
Galapagos NV – collaboration on decentralized CAR-T cell therapy manufacturing for hematological malignancies and solid tumors.
Beyond the preview
Go deeper on NecstGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NecstGen.